Artificial liver support with Cytosorb and continuous veno-venous hemodiafiltration versus advanced organ support (ADVOS) for critically ill patients with hyperbilirubinemia and acute-on-chronic liver failure (ACLF)
Artificial liver support with Cytosorb and continuous veno-venous hemodiafiltration versus advanced organ support (ADVOS) for critically ill patients with hyperbilirubinemia and acute-on-chronic liver failure (ACLF)
Bartosz Tyczynski, Kristina Schönfelder, Laurence Hirsch, Michael Jahn et al.
Journal
BMC Nephrology
Topics
Liver Disease and Transplantation
article
Artificial liver support with Cytosorb and continuous veno-venous hemodiafiltration versus advanced organ support (ADVOS) for critically ill patients with hyperbilirubinemia and acute-on-chronic liver failure (ACLF)
Bartosz Tyczynski, Kristina Schönfelder, Laurence Hirsch, Michael Jahn, Justa Friebus‐Kardash, Andreas Kribben
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC NephrologyVol. 26(1)
Institutions
Essen University Hospital (DE), Alfried Krupp Hospital (DE), University of Duisburg-Essen (DE)